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INTRODUCTION
Peptic ulcers affect a large portion of the population world-
wide and are commonly induced by Helicobacter pylori infec-
tion or one of several other factors including stress, smoking,
and the ingestion of non-steroidal anti-inflammatory drugs
(NSAIDs) (1, 2). Currently, the relatively higher incidence of
gastric ulcers in the elderly and the expanded use of NSAIDs,
along with alcohol ingestion and stress have been shown to
increase with aging (3). The approach to the treatment of
peptic ulcer disease includes inhibition of gastric acid secre-
tion by H2 receptor blockers or proton pump inhibitors (PPIs)
as well as eradication of H. pylori. However, development of
tolerance to such treatments and the incidence of relapse as
well as side effects interfere with their clinical usefulness. There-
fore, new antiulcer drugs are under investigation.
Cochinchina momordica is the dried ripe seed of Momordi-
ca cochinchinensis, a perennial vine that grows in southern China
and Vietnam, and is known for its anti-inflammatory activi-
ty against suppurative skin infections (4). Chemical analysis
shows that the cochinchina momordica seeds are composed
of compounds including fatty acids, saponins, proteins, a-
spinasterol, oleanolic acid, and momordica acid (4). Among
these compounds, momordica saponin I, glycoside, a triter-
penoid saponin containing disaccharide chain, has been found
to be a major active ingredient (5). Recently, we reported that
SK-MS10, an extract from cochinchina momordica seeds,
has gastroprotective effects against acute gastric mucosal dam-
age by suppressing proinflammatory cytokines, down-regu-
lating cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-
LOX), and increasing the synthesis of mucus in an acute gas-
tric mucosal damage model, using ethanol and water immer-
sion restraint stress (WRS) (6). Furthermore, we demonstrat-
ed that the calcitonin gene-related peptide (CGRP)-nitric
oxide (NO) pathway played an important role in the gastro-
protective effects of SK-MS10 (6). 
The so-called acetic acid ulcer model has been shown to be
a useful model for investigating the pathophysiology of gas-
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Enhancement of Gastric Ulcer Healing and Angiogenesis by
Cochinchina Momordica Seed Extract in Rats
Cochinchina momordica seed is the dried ripe seed of Momordica cochinchinensis,
a perennial vine. The antiulcer effect of an extract from cochinchina momordica
seeds (SK-MS10) was evaluated in a rat model of acetic acid-induced gastric ulcers.
Gastric ulcers were produced by subserosal injection of acetic acid. SK-MS10 (200
mg/kg) or vehicle was administered orally once per day for 14 days after the acetic
acid injection. The stomach was removed and the ulcer size measured at day 7 and
14 of the treatment. Expression of vascular endothelial growth factor (VEGF) was
assessed by real-time RT-PCR and Western blot analysis. In addition, the microvas-
culature density (MVD) adjacent to the ulcer margin was examined by immunohis-
tochemistry. The treatment with SK-MS10 for 7 and 14 days significantly accelerat-
ed ulcer healing and increased the expression of mRNA (at day 7) as well as VEGF
protein (at day 14) compared to the vehicle-treated rats. The MVD for factor VIII
was also higher in the SK-MS10 treatment group compared to the vehicle-treated
rats; however, these differences were not statistically significant. These results sug-
gest that SK-MS10 treatment accelerates the healing of gastric ulcers via upregu-
lation of VEGF and angiogenesis in an acetic acid rat model. 
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Factor; Angiogenesis
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mimics human ulcers in terms of both pathophysiological
features and healing mechanisms. To investigate whether SK-
MS10 improves the healing of gastric ulcers, and to evaluate
the mechanisms involved, we used the acetic acid-induced
ulcer rat model in this study. The goal of this study was to
investigate the effects of SK-MS10 on angiogenic responses
such as the microvasculature density, and the expression of
vascular endothelial growth factor (VEGF).
MATERIALS AND METHODS
Preparation and composition of SK-MS10 
Five liter of aqueous ethanol solution was added to one kg
(dry weight) of cochinchina momordica, purchased at an herb
market in Korea. Extraction was performed for 4 hr at 80℃,
and this process was performed twice. The extract was filtered
and concentrated under reduced pressure at 60℃using a rotary
evaporator. After complete removal of the solvent in a vacu-
um oven, 60 g of ethanol extract in powder form (SK-MS10)
was obtained. SK-MS10 was dissolved in the carboxymethyl-
cellulose (CMC) during the experiment.
Animals 
Seven-week-old male Spraque-Dawley rats (Orient Co. Ltd.,
Seoul, Korea) were housed in a cage maintained at 23℃, 12/
12-hr light/dark cycles under specific pathogen-free condi-
tions. After 1 week of adaptation, the 8-week-old rats weigh-
ing 250-300 g were used for the experiments. The rats were
starved but allowed water for 12 hr prior to the experiments.
All experimental procedures described here were approved
by the Institutional Animal Care and Use Committee (IA-
CUC) of Seoul National University (SNU-070419-2).
Induction of the gastric ulcer 
Gastric ulcers were induced with acetic acid treatment,
according to a previously described method (8). Briefly, the
fasting rats were anesthetized with an intramusclular injec-
tion of 80 mg/kg of ketamine, and then their stomachs were
exposed via a midline incision. Acetic acid (20%, 30 mL) was
injected into the subserosal layer at the junction of the anterior
wall of the antrum and corpus using a microsyringe (Hamil-
ton Co., Reno, NV, USA). The abdominal incision was then
sutured closed. From day 1 after ulcer induction, the rats were
treated with SK-MS10 (200 mg/kg) or a vehicle by gavage.
The rats were sacrificed on day 7 or 14. Each experimental
group consisted of six animals. After measuring the size of
the ulcer, the ulcer tissue was cut in half. One half was used
for histological and immunohistochemical examination, while
the other was used for mRNA level assays. As soon as the
mucosa was collected, it was stored in liquid nitrogen and
the samples were kept in a -80℃ freezer until used for the
experiments. 
Ulcerated area determination 
After the animals were sacrificed, the isolated stomachs were
cut open along the greater curvature and washed in ice-cold
saline. To assess the degree of gross mucosal damage, the mu-
cosal sides of the stomachs were photographed using a digi-
tal camera, and part of the mucosa was immediately fixed with
a 10% formalin solution. After fixed in formalin overnight,
the stomach was opened along the greater curvature and spread
out with pins on a cork board, and then photographed. The
ulcerated area (mm2) was quantified using the following equa-
tion: S=p (d1/2)×(d2/2), where S represented the ulcerated
area (mm2), d1 and d2 the longest longitudinal and transverse
diameters of the ulcer.
Immunohistochemical staining for von willebrand factor 
For the angiogenesis studies, the sections were incubated
with an antibody for the von Willebrand factor (factor VIII-
related endothelial antigen; Chemicon International, Temec-
ula, CA, USA) after deactivation of endogenous peroxidase
with 0.3% H2O2 and blocking of nonspecific binding sites.
The microvasculature was visualized by the avidin-biotin-
peroxidase complex method. The degree of microvasculature
found in the ulcer base granulation tissue was determined
in three randomly chosen 1 mm2 fields. The microvascula-
ture density was expressed as the number of vessels per mm2
of the ulcer base.
Western blotting for VEGF 
The gastric mucosa was homogenized with lysis buffer con-
taining 25 mM Tris-HCl (pH 7.4), EGTA (1 mM), DTT (1
mM), leupeptin (10 mg/mL), aprotinin (10 mg/mL), PMSF
(1 mM), and Triton X-100 (0.1%). Briefly, the proteins (each
sample, 30 mg) were separated by SDS-PAGE (7.5% wt/wt
gel) and transferred to nitrocellulose membranes. All proce-
dures were carried out in Tris buffer (40 mM, pH 7.55) con-
taining 0.3 M of NaCl and 0.3% Tween 20. The membranes
were then blocked with dried milk (6% wt/vol), and subse-
quently incubated with VEGF antibody (mouse monoclon-
al antibody, 1:500; Chemicon International) at 4℃overnight.
The blots were incubated with secondary antibody (goat anti-
mouse polyclonal antibody, 1:500; Santa Cruz Biotechnolo-
gy, Santa Cruz, CA, USA) and an imaging analyzer was used
to measure the band densities.
Real time PCR for VEGF 
RNA was extracted from the gastric mucosa using the
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ing to the manufacturer’s instructions. RNA samples were
diluted to a final concentration of 0.5 mg/mL in RNase-free
water and stored at -80℃ until use. Synthesis of the cDNA
was performed with 1 mg of total RNA with M-MLV Reverse
Transcription Reagents (Invitrogen, Carlsbad, CA, USA). The
20-mL reverse transcription reaction consisted of 4 mL of First-
strand buffer, 500 mM deoxynucleoside triphosphate mix-
ture, 2.5 mM oligo (dT)12-18 primer, 0.4 U/mL ribonuclease
inhibitor, and 1.25 U/mL Moloney murine leukemia virus
reverse transcriptase (Invitrogen). The thermal cycling param-
eters for the reverse transcription were 5 min at 65℃, 50 min
at 37℃ and 15 min at 70℃. Real time PCR amplification
and determination were performed using the ABI PRISM
7000 Sequence Detection System, TaqMan universal PCR
master mix, commercially available predesigned, gene spe-
cific primers, and FAM-labelled probe sets for quantitative
gene expression (TaqMan Gene Expression Assays, rodent
VEGF, mouse b-actin; Applied Biosystems, Foster City, CA,
USA). All of the probes used in these experiments spanned
an exon-intron boundary. The VEGF and b-actin mRNA was
quantified by parallel estimation. The thermal cycler condi-
tions were 2-min hold at 50℃ and 10-min hold at 95℃,
followed by 40 cycles of 15 s at 95℃and 1 min at 60℃. 
Statistical analysis 
All statistical calculations were performed using SPSS soft-
ware (version 12.0; SPSS Inc., Chicago, IL, USA). The results
were compared using the Mann-Whitney U test and the Wil-
coxon rank sum test. All values are reported as means±stan-
dard errors. Statistical significance was set at Pvalue <0.05.
RESULTS
Gastric ulcer healing with SK-MS10 
SK-MS10 significantly accelerated ulcer healing by day 7
and day 14. That is, compared to the vehicle-treated group
(Fig. 1A, B) the mean ulcer size in the SK-MS10-treated group
(Fig. 1C, D) was significantly smaller by day 7 and 14 after
ulcer induction. Numerically, the ulcer area 7 and 14 days
after SK-MS10 treatment was 33.2 mm2 and 9.3 mm2, res-
pectively, which was smaller than the 52.6 mm2 and 32.3
mm2 size of the vehicle treated group (Fig. 1E).
Expression of factor VIII in the ulcer mucosa
As shown in Fig. 2, microvessels were stained brown using
the von Willebrand factor antibody. The microvasculature
density (MVD) in the SK-MS10 treated group was increased
compared to the vehicle treated group; however, this differ-
ence did not reach statistical significance. That is, the mic-
rovessel densities in the ulcer granulation tissues of the SK-
MS10 treated rats on day 7 and 14 were 40.8 vessels/mm2
and 36.8 vessels/mm2, respectively, which was higher than in
the vehicle treated rats (32.4 vessels/mm2 and 24.2 vessels/
mm2, respectively).
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Fig. 1. Effects of SK-MS10 on the healing of gastric ulcers. Macroscopic appearance of ulcers generated at the gastric mucosa in the vehi-
cle treated group at 7 and 14 days (A, B) and the SK-MS10 treated group at 7 and 14 days (C, D). Arrows indicate ulcer. (E) Summarized
results on changes of the ulcer area in the vehicle and SK-MS10 treated groups. Results are the mean±SE in 6 animals per group.
*P value <0.05 when compared with the vehicle treated group. Expression of VEGF in the ulcer mucosa
The mRNA expression of VEGF after 7 days of SK-MS10
treatment was significantly higher than in the vehicle treat-
ed group (0.7 vs. 5.4 for VEGF/b-actin, respectively Fig. 3A).
However, the mRNA expression of VEGF after 14 days of
SK-MS10 treatment was not significantly different from the
vehicle treated group (Fig. 3A). On Western blot analysis, the
expression of VEGF proteins 14 days after SK-MS10 treat-
ment was significantly higher than in the vehicle group (2.7
vs. 6.0 for VEGF/b-actin, respectively Fig. 3B). However,
the protein expression of VEGF 7 days after SK-MS10 treat-
ment was not significantly different from the vehicle treated
group (Fig. 3B). 
DISCUSSION
Since introduced in 1969 by Takagi et al. (9), the acetic
acid-induced gastric ulcer model has proved useful for inves-
tigating the pathophysiology of gastric ulcer disease and the
efficacy of antiulcer drugs (7). The reasons for the usefulness
of this model include the following. First, the ulcer induction
procedure is simple, readily resulting in ulcers of consistent
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Fig. 2. Effects of SK-MS10 on angiogenesis in the gastric ulcer. Immunochemical staining of microvessels with the von Willebrand factor
in the ulcer bases of rats in the vehicle treated group at 7 and 14 days (A, B) and the SK-MS10 treated group at 7 and 14 days (C, D). Note
the von Willebrand factor positive cells (dark brown spots indicated by arrows). (E) The number of microvessels at the gastric ulcer bases
of the rats in the vehicle and the SK-MS10 treated groups. Results are mean±SE in 6 animals per group.
*P value <0.05 when compared with the vehicle treated group. 
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Fig. 3. Effects of SK-MS10 on the expression of VEGF. (A) The relative mRNA expression of VEGF. (B) Western blot analysis for VEGF. Results
are mean±SE in 6 animals per group.*P value <0.05 when compared with the vehicle treated group.
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b-actinsize and severity with a 100% success rate. Second, the acetic
acid-induced ulcers resemble human peptic ulcers both macro-
scopically and histologically. Indeed, spontaneous relapse of
healed ulcers is frequently observed, just as in patients with
peptic ulcer disease. Finally, the ulcers respond well to vari-
ous anti-ulcer drugs, such as PPI, sucralfate and several growth
factors. In this study, we investigated the effects of SK-MS10
on the healing of this type of experimental ulcer in the rat,
and found that oral administration of SK-MS10, at a dose of
200 mg/kg for 7 and 14 days, accelerated the healing of the
gastric mucosa in the rat model.
The regrowth of blood vessels into the ulcerated area, i.e.,
angiogenesis, plays a pivotal role in the acceleration of the
healing of ulcers since the neovasculature promotes nutrient
supply to the healing tissue (10). This complex sequence of
events requires a high degree of coordination among differ-
ent cell types, which is regulated by several factors. Among
them, growth factors such as the vascular endothelial growth
factor (VEGF), basic fibroblast growth factor (bFGF) and their
receptors are known to play an important role in tissue repair
and the healing of ulcers (11, 12). VEGF, previously described
as a vascular permeability factor, is also known as a growth
factor that is involved in the mucosal protection and the angio-
genic response that occurs during the healing of ulcers (13).
Specific expression of VEGF has been demonstrated at the
ulcer margin in humans (14). In addition, exogenous VEGF
has been reported to significantly enhance the healing of acute
gastric mucosal injury induced by ethanol and duodenal ulcer-
ation (15). Furthermore, local injection of plasmid-DNA en-
coding VEGF has been shown to stimulate the healing of
ulcers in the rat (16). By contrast, NSAIDs, cyclooxygenase-
2 (COX-2) inhibitors, and alendronate have been shown to
delay the healing of ulcers, and impair angiogenesis and the
down regulation of growth factors such as bFGF and VEGF
(17-19). Recently, the saponins isolated from Red Ginseng
exhibited wound healing of burns in mice and promoted
angiogenesis via the stimulation of VEGF production (20).
In the present study we found that SK-MS10, with momordi-
ca saponin as a major component, enhanced the expression
of VEGF by stimulation of angiogenesis in the gastric mucosa
of the rat, similar to the effects of Red Ginseng. This expres-
sion of VEGF has been reported to be upregulated by COX-
2 derived prostaglandin E2 (PGE2) (21). Thus, it might be
valuable to investigate whether SK-MS10 could induce COX-
2/PGE2 production in acetic acid induced ulcer. Besides some
bioactive components, cochinchina momordica are also rich
in protease inhibitors. Several trypsin inhibitors and chymo-
trypsin inhibitor have been isolated (22-25). Protease inhibitor
from cochinchina momordica has been reported to possess
antioxidative activities in the rat hepatocyte (26). In addition,
high carotinoid contents such as carotene, lycophene are known
to be detected in the active fraction of cochinchina momordi-
ca seed membrane (27). Carotenoids also are known to potent
antioxidative activity and have been reported to have anti-
ulcerogenic effect on ulcer models in rat (28). These antiox-
idative components of the seeds may provide a favorable en-
vironment for ulcer healing and the anti-ulcerogenic effect.
However, further studies with these isolates from cochinchi-
na momordica and phytochemical analysis are needed to clar-
ify the main contributor of the mechanism on ulcer healing.
Interestingly, the duration of treatment for the detection of
a significant difference was different for the mRNA and the
protein expression. That is, the mRNA expression of VEGF
7 days after SK-MS10 treatment, and the expression of VEGF
proteins 14 days after SK-MS10 treatment were significant-
ly higher than in the control group. This discrepancy might
be due to the lag time between the translation of mRNA and
the expression of the protein. In addition, it is possible that
the VEGF expression is regulated at the post-translational
level, although further studies are necessary to clarify this.
MVD assessment is the most commonly used technique
to quantify angiogenesis. Initially, we used antibodies direct-
ed against platelet endothelial cell adhesion molecules, CD31
and CD34; commonly used for the assessment of angiogen-
esis in several prior studies (29-31). However, these antibod-
ies did not work properly for staining the microvessels even
after several trials. As an alternative marker, we used an anti-
body against the factor VIII-related antigen, also known as
the von Willebrand factor, staining mainly the mature vessels
and cross reacting lymphatic endothelium (32). This marker,
in the SK-MS10 treated group, was increased compared to
the vehicle treated group; however, the difference did not reach
statistical significance. The relatively small sample size (n=6)
might have limited the power to detect a significant differ-
ence between the two groups. This finding may also be partly
due to the variation in the assessment of the MVD, depend-
ing on the fields examined, and the experience of the pathol-
ogist. So, further study extending the number of animals is
needed to clarify the effect on the angiogenesis of SK-MS10
for strengthening the statistical power. However, the increas-
ing tendency of the MVD with SK-MS10 treatment was sup-
ported by the results of enhanced expression of VEGF by using
the real-time PCR and Western blot analysis. 
Several studies have provided evidence for a role of senso-
ry neuron in gastric ulcer healing. Sensory nerve ablation by
high dose capsaicin impaired the ulcer healing (33). Recent-
ly, Ohno et al. has demonstrated that CGRP had proangio-
genic activity associated with the enhancement of ulcer heal-
ing using CGRP knockout mice (30). We previously report-
ed that SK-MS10 has a gastroprotective effect against acute
gastric mucosal damage using a model with ethanol and WRS
(6). These gastroprotective effects were found to be mediat-
ed by the upregulation of CGRP. Thus CGRP might play a
role in the ulcer healing by SK-MS10 in the acetic acid-in-
duced ulcer model. Actually CGRP has been known to be the
major transmitter from afferent nerve fibers and suppress acid
output (34). Thus, there is a possibility of the stimulation of
CGRP by SK-MS10 could contribute to the antisecretory
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tant role in impairing ulcer healing (19, 35). IL-1b has been
used in a model of induction of gastric ulcer recurrence; ap-
proximately 80-100% of healed ulcers recur at the sites of
scarred mucosa within 48 h after injection of IL-1b (36). In
a previous study, we demonstrated that SK-MS10 reduced
the increases of mucosal myeloperoxidae, IL-1b, and TNFa
levels in an acute mucosal damage model using ethanol and
WRS (6). This result further suggested that SK-MS10 have
potent inhibitory effect on inflammation, which may also
contribute to the enhancement of ulcer healing. In addition
to this gastroprotective effect of SK-MS10 we identified an
additional mechanism of VEGF expression associated with
the anti-ulcer effects of SK-MS10 in the chronic ulcer model
using acetic acid in the rat. 
In conclusion, the results of this study suggest that SK-
MS10 accelerates the healing of acetic acid induced gastric
ulcers in rats by enhancing angiogenesis and the expression
of the angiogenic growth factor, VEGF. These findings sug-
gest that SK-MS10 might be an alternative treatment of gas-
tric ulcer disease in humans sometime in the near future. In
addition, acetic acid ulcer models appear to be quite useful
for pharmacological studies of anti-ulcer drug.
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